Clinical Trials Browser

OTHER_GOV × nedaplatin × Gastrointestinal × Clear all

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms